CODX - MCAP CO - Co-Diagnostics, Inc.

Co-Diagnostics, Inc. (CODX) is building a closed-loop molecular research ecosystem where the combination of hardware and proprietary reagents maximizes customer brand loyalty. The business leverages the humanitarian status of medicine, which minimizes geopolitical threats. The price action of the company, which has a market capitalization of 0.01, is presented below. Superior diagnostic accuracy is achieved through innovative primers that completely eliminate the risk of false-positive diagnoses.

Market capitalization determines the total value of a business in the eyes of investors, calculated as the product of the current share price and the total number of outstanding shares. By analyzing an issuer's market capitalization, one can quickly identify the scale of corrections or growth phases in valuation. For Co-Diagnostics, Inc. (CODX), the dynamics of this metric reflect confidence in its intellectual property. Patent protection for PCR testing methods and the complexities of certification create the fundamental basis for the company's value.